Agoniste And NotE. Gabriela Chiorean
List of bibliographic references
Number of relevant bibliographic references: 8.Ident. | Authors (with country if any) | Title |
---|---|---|
000E34 | Bret D. Wallace [États-Unis] ; Matthew R. Redinbo [États-Unis] | Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective |
001165 | YONGJIE MA [États-Unis] ; YIXIAN HUANG [États-Unis] ; LINNA YAN [États-Unis] ; MINGMING GAO [États-Unis] ; DEXI LIU [États-Unis] | Synthetic FXR Agonist GW4064 Prevents Diet-Induced Hepatic Steatosis and Insulin Resistance |
001B71 | Michael W. Sinz [États-Unis] | Evaluation of pregnane X receptor (PXR)-mediated CYP3A4 drug-drug interactions in drug development |
001C38 | Mitsuhiro Fukuda [États-Unis] ; Alberto L. Vazquez [États-Unis] ; XIAOPENG ZONG [États-Unis] ; Seong-Gi Kim [États-Unis] | Effects of the α2-adrenergic receptor agonist dexmedetomidine on neural, vascular and BOLD fMRI responses in the somatosensory cortex |
001E38 | GUANG WANG [République populaire de Chine] ; LIYUN HE [République populaire de Chine] ; JINBO LIU [République populaire de Chine] ; JIE YU [République populaire de Chine] ; XINHENG FENG [République populaire de Chine] ; FUWANG LI [République populaire de Chine] ; YANTING HAO [République populaire de Chine] ; JIEMING MAO [République populaire de Chine] ; TIANPEI HONG [République populaire de Chine] ; Alex F. Chen [États-Unis] ; XIAN WANG [République populaire de Chine] | Coronary Flow Velocity Reserve is Improved by PPAR-α Agonist Fenofibrate in Patients with Hypertriglyceridemia |
002A79 | Elizabeth M. Oliva [États-Unis] ; Alex H. S. Harris [États-Unis] ; Jodie A. Trafton [États-Unis] ; Adam J. Gordon [États-Unis] | Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors |
002F65 | C. H. Fry [Royaume-Uni] ; J. S. Young [Royaume-Uni] ; R. I. Jabr [Royaume-Uni] ; C. Mccarthy [États-Unis] ; Y. Ikeda [États-Unis] ; A. J. Kanai [États-Unis] | Modulation of spontaneous activity in the overactive bladder: the role of P2Y agonists |
003854 | Ahmad A. Tarhini [États-Unis] ; Lisa H. Butterfield [États-Unis] ; Yongli Shuai [États-Unis] ; William E. Gooding [États-Unis] ; Pawel Kalinski [États-Unis] ; John M. Kirkwood [États-Unis] | Differing Patterns of Circulating Regulatory T Cells and Myeloid-derived Suppressor Cells in Metastatic Melanoma Patients Receiving Anti-CTLA4 Antibody and Interferon-α or TLR-9 Agonist and GM-CSF With Peptide Vaccination |
This area was generated with Dilib version V0.6.38. |